Indivior PLC logo

Indivior PLC

NAS:INDV (USA)   Ordinary Share
$ 17.37 +0.65 (+3.89%) 07:08 PM EST
1,737.00
P/B:
217.13
Volume:
116.46K
Avg Vol (2M):
104.00K
Also Trade In:
Volume:
116.46K
1,737.00
Avg Vol (2M):
104.00K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for INDV ( Indivior PLC ) from 2014 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Indivior PLC stock (INDV) PE ratio as of May 24 2024 is 1737. More Details

Indivior PLC (INDV) PE Ratio (TTM) Chart

To

Indivior PLC (INDV) PE Ratio (TTM) Historical Data

Total 1237
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Indivior PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-25 NaN 2024-03-22 At Loss
2024-05-24 NaN 2024-03-21 At Loss
2024-05-23 NaN 2024-03-20 At Loss
2024-05-22 NaN 2024-03-19 At Loss
2024-05-21 NaN 2024-03-18 At Loss
2024-05-20 NaN 2024-03-15 At Loss
2024-05-17 NaN 2024-03-14 At Loss
2024-05-16 NaN 2024-03-13 At Loss
2024-05-15 NaN 2024-03-12 At Loss
2024-05-14 NaN 2024-03-11 At Loss
2024-05-13 NaN 2024-03-08 At Loss
2024-05-10 NaN 2024-03-07 At Loss
2024-05-09 NaN 2024-03-06 At Loss
2024-05-08 NaN 2024-03-05 At Loss
2024-05-07 NaN 2024-03-04 At Loss
2024-05-06 NaN 2024-03-01 At Loss
2024-05-03 NaN 2024-02-29 At Loss
2024-05-02 NaN 2024-02-28 At Loss
2024-05-01 NaN 2024-02-27 At Loss
2024-04-30 NaN 2024-02-26 At Loss
2024-04-29 NaN 2024-02-23 At Loss
2024-04-26 NaN 2024-02-22 At Loss
2024-04-25 NaN 2024-02-21 At Loss
2024-04-24 NaN 2024-02-20 At Loss
2024-04-23 NaN 2024-02-16 At Loss
2024-04-22 NaN 2024-02-15 At Loss
2024-04-19 NaN 2024-02-14 At Loss
2024-04-18 NaN 2024-02-13 At Loss
2024-04-17 NaN 2024-02-12 At Loss
2024-04-16 NaN 2024-02-09 At Loss
2024-04-15 NaN 2024-02-08 At Loss
2024-04-12 NaN 2024-02-07 At Loss
2024-04-11 NaN 2024-02-06 At Loss
2024-04-10 NaN 2024-02-05 At Loss
2024-04-09 NaN 2024-02-02 At Loss
2024-04-08 NaN 2024-02-01 At Loss
2024-04-05 NaN 2024-01-31 At Loss
2024-04-04 NaN 2024-01-30 At Loss
2024-04-03 NaN 2024-01-29 At Loss
2024-04-02 NaN 2024-01-26 At Loss
2024-04-01 NaN 2024-01-25 At Loss
2024-03-28 NaN 2024-01-24 At Loss
2024-03-27 At Loss 2024-01-23 At Loss
2024-03-26 At Loss 2024-01-22 At Loss
2024-03-25 At Loss 2024-01-19 At Loss

Indivior PLC (INDV) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.